183 related articles for article (PubMed ID: 35703127)
21. The emerging roles of the CDK/cyclin complexes in antiviral innate immunity.
Zheng C; Tang YD
J Med Virol; 2022 Jun; 94(6):2384-2387. PubMed ID: 34964486
[TBL] [Abstract][Full Text] [Related]
22. The role of controlled proteolysis in cell-cycle regulation.
Udvardy A
Eur J Biochem; 1996 Sep; 240(2):307-13. PubMed ID: 8841392
[TBL] [Abstract][Full Text] [Related]
23. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression.
Loyer P; Trembley JH
Semin Cell Dev Biol; 2020 Nov; 107():36-45. PubMed ID: 32446654
[TBL] [Abstract][Full Text] [Related]
24. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.
Hydbring P; Malumbres M; Sicinski P
Nat Rev Mol Cell Biol; 2016 May; 17(5):280-92. PubMed ID: 27033256
[TBL] [Abstract][Full Text] [Related]
25. Current concepts in neuro-oncology: the cell cycle--a review.
Dirks PB; Rutka JT
Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
[TBL] [Abstract][Full Text] [Related]
26. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic targets in cancer treatment: Cell cycle proteins.
Selvaraj C
Adv Protein Chem Struct Biol; 2023; 135():313-342. PubMed ID: 37061336
[TBL] [Abstract][Full Text] [Related]
28. Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention.
Sankaranarayanan R; Valiveti CK; Dachineni R; Kumar DR; Lick T; Bhat GJ
Mol Med Rep; 2020 Jan; 21(1):20-34. PubMed ID: 31746356
[TBL] [Abstract][Full Text] [Related]
29. Complexities in the development of cyclin-dependent kinase inhibitor drugs.
Sausville EA
Trends Mol Med; 2002; 8(4 Suppl):S32-7. PubMed ID: 11927285
[TBL] [Abstract][Full Text] [Related]
30. Expression and Purification of Recombinant Cyclins and CDKs for Activity Evaluation.
Gallastegui E; Bachs O
Methods Mol Biol; 2016; 1336():9-12. PubMed ID: 26231704
[TBL] [Abstract][Full Text] [Related]
31. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
33. Cyclin dependent kinases in cancer: potential for therapeutic intervention.
Canavese M; Santo L; Raje N
Cancer Biol Ther; 2012 May; 13(7):451-7. PubMed ID: 22361734
[TBL] [Abstract][Full Text] [Related]
34. Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells.
Manohar SM; Joshi KS
Expert Opin Ther Targets; 2023 Mar; 27(3):251-261. PubMed ID: 37015886
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.
Mikhail S; Albanese C; Pishvaian MJ
Am J Pathol; 2015 May; 185(5):1185-97. PubMed ID: 25747534
[TBL] [Abstract][Full Text] [Related]
36. Cyclins, CDKs and cancer.
Pines J
Semin Cancer Biol; 1995 Apr; 6(2):63-72. PubMed ID: 7647308
[TBL] [Abstract][Full Text] [Related]
37. Cyclin-dependent kinase inhibitors: novel anticancer agents.
Mani S; Wang C; Wu K; Francis R; Pestell R
Expert Opin Investig Drugs; 2000 Aug; 9(8):1849-70. PubMed ID: 11060782
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
39. Role of cyclinT/Cdk9 complex in basal and regulated transcription (review).
Napolitano G; Majello B; Lania L
Int J Oncol; 2002 Jul; 21(1):171-7. PubMed ID: 12063565
[TBL] [Abstract][Full Text] [Related]
40. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Santo L; Siu KT; Raje N
Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
